|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 SEK | -0.78% |
|
+1.99% | -51.33% |
NextCell Pharma AB reported earnings results for the first quarter ended November 30, 2022. For the first quarter, the company reported sales was SEK 2.14 million compared to SEK 1.35 million a year ago. Revenue was SEK 3.01 million compared to SEK 1.35 million a year ago.
Net loss was SEK 8.92 million compared to SEK 6.47 million a year ago. Basic loss per share from continuing operations was SEK 0.26 compared to SEK 0.19 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -51.33% | 4.14M | |
| +33.63% | 50.85B | |
| -0.09% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +11.18% | 26.11B | |
| -21.95% | 19.13B | |
| +8.61% | 13.05B | |
| +28.31% | 12.16B | |
| +24.73% | 12.08B |
NEXTCELL PHARMA AB 
